HIV+ group (n = 90) | PEP group (n = 81) | |
---|---|---|
Aged <45 | 29 (32%) | 67 (83%) |
Offered SHS | 47 (52%) | 73 (90%) |
Accepted SHS | 33 (70%) | 68 (93%) |
Positive for STI | 8 (24%) | 25 (37%) |
Asked about RDU | 40 (44%) | 78 (96%) |
Ever used RDU | 18 (45%) | 38 (48%) |
Used RDU in last 6 months | 8 (44%) | 37 (97%) |
RDU considered problematic | 2 (25%) | 14 (37%) |
The most commonly used drug was mephedrone (81% in PEP group vs 38% in HIV+ group) followed by crystal methamphetamine (54% vs 12.5%). 2/81 (2.4%) in the PEP group tested HIV positive within 3 months of follow up.